Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00100-2/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_escmid24&_hsenc=p2ANqtz--U89Rx-Us2tUl94Nw_iiEWTzHZmT1haI1i33kS4aOQYX4q1s0gQJRfUNgaV4nsEkK4V56DGKpXu2b9vS10lQ3mkA2ioQ&_hsmi=304769903&utm_content=304769903&utm_source=hs_email